Abstract P108: In vivo CRISPR screens identify E3 ligase COP1 as a modulator of macrophage infiltration and cancer immunotherapy target
Xiaoqing Wang(Roche (China)), X. Shirley Liu(Harbin Medical University), Clifford A. Meyer(Dana-Farber Cancer Institute), Shengqing Gu(Dana-Farber Cancer Institute), Peng Jiang(King Center), Klothilda Lim(Dana-Farber Cancer Institute), Tengfei Xiao(Lanzhou University), Myles Brown(Harvard University), Nicole Traugh(Tongji University), Jingxin Fu(Tongji University), Henry W. Long(Dana-Farber Cancer Institute), Zexian Zeng(Peking University), Qin Tang(University of Electronic Science and Technology of China), Wei Li(Shenyang University of Technology), Yi Zhang(Case Western Reserve University), Binbin Wang(National Cancer Institute), Yihao Li(Second Affiliated Hospital of Guangzhou Medical University), Paloma Cejas(Dana-Farber Cancer Institute), Boning Zhang(Harvard University), Collin Tokheim(Johns Hopkins University)
Cited by 1
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k
Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
|Nature Communications|2019|1.1k
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
|Journal of Clinical Investigation|2011|928